PHILADELPHIA--(BUSINESS WIRE)--Philadelphia-based National Disease Research Interchange (NDRI), the nation’s premier provider of human biospecimens to advance medical disease research, announces the election of Mary J.C. Hendrix, PhD, as Chair of the Board of Directors. Dr. Hendrix was elected by unanimous vote at the fall meeting of the NDRI Board on October 29, 2015.
Dr. Hendrix currently serves as the President and Chief Scientific Officer of the Stanley Manne Children’s Research Institute, and holds the Children’s Research Fund and the William G. Swartchild, Jr. Distinguished Research endowed professorships, and is a member of the Robert H. Lurie Comprehensive Cancer Center. The Manne Research Institute is part of Ann & Robert H. Lurie Children’s Hospital of Chicago and affiliated with Northwestern University’s Feinberg School of Medicine. Prior to joining Northwestern University, she was on the faculty of the University of Iowa as the Leading Woman Scientist Endowment Recipient and Head of the Department of Anatomy and Cell Biology. She also served as the Kate Daum Research Professor and Associate Director of Basic Research and Deputy Director of The Holden Comprehensive Cancer Care Center.
“I am honored to have been elected Chair of the NDRI Board of Directors,” said Dr. Hendrix. “Access to high quality human tissue is vital to basic scientific research, translational research and drug development and testing. I look forward to continuing to work with the board and staff of NDRI in our work to support the global research community,” she added.
“I have known Dr. Hendrix for many years and am certain that she will provide exceptional leadership in her role as Chair of the NDRI Board of Directors,” said Meenhard Herlyn, DVM, DSc, outgoing Chairman of the NDRI Board and Director of The Wistar Institute Melanoma Research Center in Philadelphia.
Dr. Hendrix is a past president of FASEB (Federation of American Societies for Experimental Biology) and the Association of Anatomy, Cell Biology and Neurobiology Chairpersons (AACBNC). She has over 250 publications in biomedical research. She currently serves on the Board of Directors of Research!America, the Annenberg Center for Health Sciences at Eisenhower Medical Center, and the Chicago Council on Science and Technology, and is a member of the editorial boards of Cancer Research, The American Journal of Pathology, Cancer Biology and Therapy, Lymphatic Research and Biology, and Journal of Cellular Biochemistry.
Bill Leinweber, President and CEO of NDRI added “We are tremendously grateful to Dr. Herlyn for his longtime commitment to NDRI. Our board of directors is very fortunate to have a leader with Dr. Hendrix’s scientific accomplishments and understanding of the critical role of human tissue in research.”
NDRI is a not-for-profit organization founded in 1980 with a mission to procure and distribute human organs, cells and tissue to advance biomedical research and development worldwide. NDRI has received support from the National Institutes of Health for 30 years. Researchers from universities, medical centers, hospitals, pharmaceutical and biotechnology companies in the U.S. and around the world rely on NDRI for human biospecimens to advance their studies in fields such as HIV/AIDS, cancer, arthritis, heart disease, cystic fibrosis and other rare diseases, and traumatic brain injury.
National Disease Research Interchange
8 Penn Center, 15th Floor
1628 JFK Boulevard
Philadelphia, PA 19103